Home  »  Industry   »  SGMO’s Stock Market Adventure: -72.37% YTD G...

SGMO’s Stock Market Adventure: -72.37% YTD Growth Amidst Volatility

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price loss of -72.37% this year. Over the last six months, there has been a stronger performance of -56.84%. The price of SGMO leaped by -5.64% during the last 30 days period. For the last 5-days stocks have slided -6.73%.

Sangamo Therapeutics Inc. (SGMO) has a current stock price of $0.87. During the previous trading session, the stock witnessed a notable rise, reaching a high of $0.99 after opening at $0.99. The stock’s low for the day was $0.84, and it eventually closed at $1.00.

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free

Sangamo Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $5.76 on 09/20/22, while the lowest price during the same period was $0.77 on 08/25/23.

52-week price history of SGMO Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Sangamo Therapeutics Inc.’s current trading price is -84.94% away from its 52-week high, while its distance from the 52-week low is 12.66%. The stock’s price range over this timeframe has been between $0.77 and $5.76. The shares of the Healthcare sector company recorded a trading volume of approximately 3.76 million for the day, which was comparatively higher than the average daily volume of 1.81 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Sangamo Therapeutics Inc. (SGMO) has experienced a quarterly decline of -23.23% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 153.79M and boasts a workforce of 478 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1994, with a change in price of -0.7425. Similarly, Sangamo Therapeutics Inc. recorded 2,025,589 in trading volume during the last 100 days, posting a change of -46.12%.

SGMO’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for SGMO stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

SGMO Stock Stochastic Average

Sangamo Therapeutics Inc.’s raw stochastic average for the past 50 days is currently at 10.83%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 25.66%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 48.84% and 61.96%, respectively.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts